Cardiac Ischemia and Reperfusion
Cardiac Ischemia and Reperfusion is a research topic within Pathology and Forensic Medicine. Science Explorer counts 33k research works in it since 1950. 19.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the pathophysiology, mechanisms, and therapeutic strategies related to myocardial reperfusion injury, including ischemic preconditioning, remote ischemic conditioning, oxidative stress, and the role of mitochondrial permeability transition pore. It also explores the involvement of various cell signaling pathways and reactive oxygen species in the context of cardioprotection and myocardial infarction.
- Ischemia-Reperfusion Injury
- Cardioprotection
- Mitochondrial Permeability Transition Pore
- Oxidative Stress
- Ischemic Preconditioning
- Remote Ischemic Conditioning
- Reactive Oxygen Species
- Myocardial Infarction
- ATP-Sensitive Potassium Channels
- Cell Signaling Pathways
- Research works
- 33k fractional, since 1950
- In the world top 10%
- 6.4k per year above
- Top-10% rate
- 19.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -11% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cardiac Ischemia and Reperfusion research?
By volume, China and the United States publish the most (846 and 559 works in 2022–2025).
By volume, 2022–2025
- 1 China 846 works
- 2 United States 559 works
- 3 Germany 119 works
- 4 Japan 95 works
- 5 Türkiye 93 works
- 6 Russia 92 works
- 7 India 87 works
- 8 United Kingdom 78 works
- 9 Iran 66 works
- 10 Italy 61 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cardiac Ischemia and Reperfusion research?
By volume in 2022–2025, Capital Medical University publishes the most Cardiac Ischemia and Reperfusion research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Tomsk National Research Medical Center.
By volume, 2022–2025
- 1 Capital Medical UniversityChina 19 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 19 works
- 3 Tomsk National Research Medical CenterRussia 13 works
- 4 Washington University in St. LouisUnited States 11 works
- 5 Nanjing Medical UniversityChina 10 works
- 6 Ain Shams UniversityEgypt 9 works
- 7 Southern Medical UniversityChina 9 works
- 8 Chiang Mai UniversityThailand 8 works
- 9 Wuhan UniversityChina 8 works
- 10 Massachusetts General HospitalUnited States 8 works
Who are the leading researchers in Cardiac Ischemia and Reperfusion?
The most-cited researchers publishing on Cardiac Ischemia and Reperfusion include Valentı́n Fuster, Salim Yusuf and Bernard J. Gersh.
- 1 Valentı́n Fuster United States 5.4k citations
- 2 Salim Yusuf Canada 4.3k citations
- 3 Bernard J. Gersh United States 4k citations
- 4 Gregg C. Fonarow United States 3.4k citations
- 5 Michael Böhm Germany 3.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cardiac Ischemia and Reperfusion research done?
The largest centres of Cardiac Ischemia and Reperfusion research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Wuhan (China).
Where is the best place to study Cardiac Ischemia and Reperfusion?
Among universities, judged by research, Capital Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College and Southern Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Capital Medical UniversityChina | 63.7 | 22.9% | 12.0× | 19 | -11.3% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 57.6 | 35.3% | 7.1× | 19 | -36.7% |
| 3 | Southern Medical UniversityChina | 53.2 | 28.9% | 8.7× | 9 | +35.4% |
| 4 | Chiang Mai UniversityThailand | 48.7 | 25.1% | 9.6× | 8 | -18.8% |
| 5 | Wuhan UniversityChina | 42.8 | 54.1% | 2.5× | 8 | +5.7% |
| 6 | Nanjing Medical UniversityChina | 41.4 | 21.7% | 7.0× | 10 | +14.6% |
| 7 | Washington University in St. LouisUnited States | 34.5 | 23.1% | 5.6× | 11 | -32.6% |
| 8 | Ain Shams UniversityEgypt | 26.9 | 5.5% | 4.4× | 9 | +34.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cardiac Ischemia and Reperfusion research growing?
Output in 2018–2022 was 11% lower than in 2013–2017, peaking in 2008.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.